Connect with us

Cannabis Now

Cannabis Now

Pennsylvania MMJ Program Not Even Close to a Done Deal

Marijuana Cannabis Now Magazine
Photo by Spot Us


Pennsylvania MMJ Program Not Even Close to a Done Deal

There was a lot of excitement coursing through the veins of cyber existence last week after the Pennsylvania House of Representatives put its seal of approval on an updated version of a bill aimed at legalizing medical marijuana. The focus of the media frenzy surrounding the passage of Senate Bill 3 centered on a number of amendments to the original language intended to create a more comprehensive program than originally proposed.

There is some evidence, however, that the latest House tweaks may be causing some trouble for the measure now that it is back in front of the Senate.

The Senate was supposed to take up the bill as early as Monday, but CBS Philly reports that this action seems to have been postponed until sometime in April. Although the reasoning behind this chamber’s decision to sandbag the issue is not immediately clear, there is speculation that lawmakers may have requested more time to assemble additional amendments to work into an alternative version.

Unfortunately, any amendment put forth by the Senate would set the bill on course for another round of deliberation with the House – creating a situation where the proposal will either linger in political purgatory or be snuffed out altogether. The Pennsylvania House majority leader said this week that if the Senate does not approve the latest version of the bill, he couldn’t promise it will be discussed again in the House.

Governor Tom Wolf, who has been eager to sign the bill since it was first introduced, said he is worried the bill will be unable to make any progress because of this tug-and-jerk match between the two chambers. “I think the leadership in both houses should have every interest in trying to get it to my desk as quickly as possible,” he said.

If the Senate does approve the current version of the bill later next month, patients suffering from around 15 qualified conditions would be allowed access to various cannabis products to be purchased from any of the projected 50 dispensaries licensed by the state. Although the original language of the measure suggested that all of the marijuana cultivated and sold in Pennsylvania would be limited to 10 percent THC, an amendment made by the House last week eliminated this restriction.

As it stands, patients with “cancer, HIV/AIDS, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, multiple sclerosis, damage to the nervous tissue of the spinal cord with objective neurological indication of intractable spasticity, epilepsy, inflammatory bowel disease, neuropathies, Huntington’s disease, Crohn’s disease, post traumatic stress disorder, intractable seizures, glaucoma, sickle cell anemia, chronic pain, and autism” would be allowed access to full strength cannabis pills, oils and tinctures. There would be no home cultivation or smokable marijuana permitted under this plan.

It is true the Senate gave approval for the original bill last year in a vote of 40 to 7, but that proposal was somewhat different than the one currently fighting to become law. Yet the Senate may surprise us and put their stamp of approval on the bill once again without incident. If that happens, it will go before Governor Wolf for his signature.

“It is long past time to provide this important medical relief to patients and families across the commonwealth,” Wolf said last week in a statement.

Do you need medical marijuana? Tell us about your experiences.



  1. DWallace32342

    March 24, 2016 at 10:10 am

    I am glad that PA is finally moving forward with this. I thank the people who have worked hard on this. Some issues with the bill remain:

    -It will take 18-24 months to implement after it is signed into law.

    -Only allows treatment for 17 serious conditions. The board can approve more conditions “Three years after the MM program commences”, meaning 4.5 to 5 years after signing.

    -Doctors are required to register with the state and complete a 4 hour course. Their information will likely be made public (possibly under the Right-To-Know Act). None of this is required for seriously harmful pharmaceuticals. This move will discourage most doctors from participating. New Jersey did the same thing which resulted in a low-turnout of physicians, and thereby a low turnout of patients.

    -Growers/processors are required to have $2,000,000 in capital with $500,000 in the bank. There is a $200,000 initial fee and $10,000 application fee. This eliminates small businesses.

    -Patients are not allowed to legally grow their own medicine, which would drastically reduce costs.

  2. travis2112

    March 24, 2016 at 8:05 am

    im from santa cruz california and i moved to PA to get closer to my mom and dad and now i cant get my medicine like i was getting in cali they need to do this why do people have to buy it ileaglly from drug dealers and get robbed and be paranoid about it too it’s just dumb that PA can’t do what every other states are doin and consitering how many people PA has i would think they would do this ,,it would make soo much money for the state !!!

  3. TheSinnedAngel

    March 24, 2016 at 7:25 am

    Same old MO as usual:
    Promise, delay, avoid..
    Repeat ad infinitum

Leave a Reply

Your email address will not be published. Required fields are marked *

More in Politics

To Top